Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 22,485,900 | 21,445,800 | 21,199,000 | 40,363,200 | 32,714,000 |
| Cost of Goods | 4,436,900 | 4,004,900 | 3,624,800 | 22,443,500 | 17,534,200 |
| Gross Profit | 18,049,000 | 17,440,900 | 17,574,200 | 17,919,700 | 15,179,800 |
| Operating Expenses | 9,481,100 | 8,330,300 | 8,157,800 | 8,512,000 | 7,268,400 |
| Operating Income | 8,568,801 | 9,111,501 | 9,417,199 | 9,408,199 | 7,911,600 |
| Other Income | 482,799 | 540,199 | 530,901 | 415,901 | 707,900 |
| Pre-tax Income | 9,051,600 | 9,651,700 | 9,948,100 | 9,824,100 | 8,619,500 |
| Income Tax | 2,462,000 | 2,856,900 | 2,894,900 | 3,002,400 | 2,729,000 |
| Net Income Continuous | 6,589,600 | 6,794,800 | 7,053,200 | 6,821,700 | 5,890,500 |
| Net Income Discontinuous | 241,300 | 354,700 | 228,600 | N/A | 0 |
| Net Income | $6,830,900 | $7,149,500 | $7,281,800 | $6,821,700 | $5,890,500 |
| EPS Basic Total Ops | 3.05 | 3.17 | 3.18 | 2.96 | 2.51 |
| EPS Basic Continuous Ops | 2.95 | 3.01 | 3.08 | 2.96 | 2.51 |
| EPS Basic Discontinuous Ops | 0.11 | 0.16 | 0.10 | N/A | N/A |
| EPS Diluted Total Ops | 3.03 | 3.14 | 3.14 | 2.90 | 2.45 |
| EPS Diluted Continuous Ops | 2.92 | 2.98 | 3.04 | 2.90 | 2.51 |
| EPS Diluted Discontinuous Ops | 0.11 | 0.16 | 0.10 | N/A | N/A |
| EBITDA(a) | $9,883,001 | $10,342,700 | $10,549,700 | $10,676,600 | $9,056,399 |